Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1993
10/05/1993US5250543 Derivatives of 1,4-dihydropyridine, their preparation procedure and therapeutic compositions containing them
10/05/1993US5250541 Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them
10/05/1993US5250540 Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use in medicaments
10/05/1993US5250539 5-alpha reductase inhibitors; administer as therapy for benign prostatic hyperplasia, hirsutism and acne
10/05/1993US5250529 Method alleviating migraine headache with mast cell degranulation blocking agents
10/05/1993US5250525 Intermediates for beta-lactamic antibiotics
10/05/1993US5250524 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
10/05/1993US5250519 Non-anticoagulant heparin derivatives
10/05/1993US5250518 O-methyl derivatives of azithromycin A
10/05/1993US5250513 Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
10/05/1993US5250442 Method of treating rheumatoid arthritis using tetracycline
10/05/1993US5250294 Improved perfusion medium for transplantation of organs
10/05/1993US5250293 Method for the treatment of hypersensitivity diseases by administration of anionic polymers
10/05/1993US5250292 Anti-aging cosmetics
10/05/1993US5250290 Using nicotinamide adenosine dinucleotide and its phosphate ester encapsulated in lipid vesicles
10/05/1993US5250286 For administering alpha-adrenergic blocking agent by inhalation
10/05/1993US5250283 Organic contrast agent analog and method of making same
10/05/1993CA1322761C Organogermanium compounds and process for producing the same
10/05/1993CA1322760C Famotidine polymorphic forms and their preparation process
10/05/1993CA1322755C Acetamide compounds
10/05/1993CA1322754C Aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them
10/05/1993CA1322753C 2-(aminoalkylthio)methyl-1,4-dihydropyridine, a method for the preparation thereof and pharmaceutical compositions containing them
10/05/1993CA1322752C Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same
10/05/1993CA1322749C Prostaglandins of the d series, and tranquilizers and soporifics containing the same
10/05/1993CA1322748C Adenosine deaminase-stable anti-retroviral nucleosides
10/05/1993CA1322723C Inhibitors for replication of retroviruses and for the expression of oncogene products
10/05/1993CA1322719C Activator for osteoblast
10/05/1993CA1322717C Combination of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents and methods for treating diseases
10/05/1993CA1322713C Compositions and methods for modulating the effect of tnf and il-1
10/04/1993CA2093262A1 Anti-skin rash preparation
10/03/1993CA2093108A1 9-fluoro-7-oxo-7h-pyrido[1,2,3-de][1,4]benzoxazine-6- carboxylic acids and esters
10/03/1993CA2093107A1 7-oxo-7h-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acids and esters
10/03/1993CA2093106A1 Use of 7-oxo-7h-pyrido[1,2,3,-de][1,4]benzoxazine-6- carboxylic acids and esters as medicaments
10/03/1993CA2064509A1 Treatment for acne
10/02/1993CA2093112A1 3-aminochromane spiro derivatives; process for preparing the same and pharmaceutical compositions containing them
10/02/1993CA2092886A1 Cycloalkyl- and heterocyclyl-substituted imidazolylpropenoic acid derivatives
10/02/1993CA2092852A1 Imidazole derivatives, their method of preparation and their application in therapeutic
10/01/1993CA2092961A1 Novel 3', 5'-di-tert-butyl-4'-hydroxyflavones; process for preparing thesame
10/01/1993CA2092885A1 Use of 3-amino-substituted isoxazole derivatives for combating endoparasites, new 3-amino-substituted isoxazole derivatives, and processes for their preparation
10/01/1993CA2092867A1 1-¬2-(arylsulfonylamine)-1-oxoethyl|piperidine derivatives, their preparation and therapeutic applications
10/01/1993CA2092861A1 Transdermal compositions
09/1993
09/30/1993WO1993019203A1 Oligonucleotide modulation of protein kinase c
09/30/1993WO1993019075A1 Antiviral phosphonic acid derivatives of purine analogues
09/30/1993WO1993019070A1 Carbapenem derivatives as antibiotics and intermediates thereof
09/30/1993WO1993019068A1 PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
09/30/1993WO1993019066A1 Imidazopyridine derivative and medicine
09/30/1993WO1993019064A1 Quinuclidine derivatives as substance p antagonists
09/30/1993WO1993019063A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
09/30/1993WO1993019061A1 Itraconazole and saperconazole stereoisomers
09/30/1993WO1993019059A1 Antiviral peptides
09/30/1993WO1993019056A1 Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
09/30/1993WO1993019052A1 3-ureido substituted benzodiazepin-2-ones having cholecystokinin and/or gastrin antagonistic activity and their use in therapy
09/30/1993WO1993019051A1 Dipeptidylquinazolones as anti-cancer agents
09/30/1993WO1993019046A1 Novel sulfonamide fibrinogen receptor antagonists
09/30/1993WO1993019044A1 Novel vitamin d analogues
09/30/1993WO1993019037A1 Compounds
09/30/1993WO1993019036A1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
09/30/1993WO1993019024A2 Mercapto-acetamide derivatives
09/30/1993WO1993018786A1 Use of a peptide
09/30/1993WO1993018779A1 A strain of streptomyces avermitilis glycosylates avermectin compounds
09/30/1993WO1993018778A1 Alkylthio alkyl avermectins are active antiparasitic agents
09/30/1993WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders
09/30/1993WO1993018776A1 Combinations of compounds having antiviral activity
09/30/1993WO1993018774A1 Use if estriol for treating climacteric osteoporosis
09/30/1993WO1993018773A1 Novel aminosterol antibiotic
09/30/1993WO1993018772A1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
09/30/1993WO1993018770A1 Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases
09/30/1993WO1993018769A2 A new use of quinazoline derivative
09/30/1993WO1993018768A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
09/30/1993WO1993018767A1 Use of sydnonimines to treat erectile dysfunction
09/30/1993WO1993018766A1 Further indole derivatives with antiviral activity
09/30/1993WO1993018765A1 Indole derivatives with antiviral activity
09/30/1993WO1993018762A2 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/30/1993WO1993018761A1 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders
09/30/1993WO1993018760A1 Use of transglutaminase inhibitor for the treatment of scar tissue
09/30/1993WO1993018758A1 Sustained release composition and method utilizing xanthan gum and an active ingredient
09/30/1993WO1993018756A1 Anion exchange resin compositions
09/30/1993WO1993018751A1 Liposome encapsulated taxol and a method of using the same
09/30/1993WO1993018750A1 Method for reducing side-effects of a drug
09/30/1993WO1993018748A1 Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
09/30/1993WO1993018746A1 Pressurized gas packagings using polyoxyethylene glyceryl-obates
09/30/1993WO1993018744A1 Agent for use as an anti-irritant
09/30/1993WO1993018741A1 Oral care compositions comprising certain substituted diphenyl ethers
09/30/1993WO1993018653A1 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds
09/30/1993WO1993018652A1 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds
09/30/1993WO1993018651A1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use
09/30/1993WO1993018650A1 Antiviral contraceptive devices, particularly condoms
09/30/1993WO1993013117A3 5- or 6-aminodeoxyfuranoside derivatives with antiinflammatory and antiproliferative activity
09/30/1993WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
09/30/1993DE4307422A1 Verfahren zur Herstellung von Clavulansäuresalzen Process for the preparation of salts of clavulanic acid
09/30/1993DE4209462A1 Treatment of impotence
09/30/1993DE4200080A1 Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung A pharmaceutical composition for wound, scar and keloid treatment
09/30/1993CA2134237A1 In vivo peptide therapy
09/30/1993CA2132319A1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use
09/30/1993CA2132310A1 Methods of achieving antileukemia activity using 16-membered macrolide-type compounds
09/30/1993CA2132303A1 Antiviral phosphonic acid derivatives of purine analogues
09/30/1993CA2132209A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
09/30/1993CA2132102A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/30/1993CA2132094A1 Oligonucleotide modulation of protein kinase c
09/30/1993CA2131615A1 Antiviral contraceptive devices, particularly condoms
1 ... 7161 7162 7163 7164 7165 7166 7167 7168 7169 7170 7171 7172 7173 7174 7175 7176 7177 7178 7179 7180 7181 ... 7860